Cardiomyopathy, Dilated
|
0.220 |
Biomarker
|
group |
MGD |
|
|
|
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
<b>Introduction:</b> Our previous study identified LIM homeobox domain 6 (LHX6) as a frequently epigenetically silenced tumor-suppressor gene in lung cancer.
|
28900494 |
2017 |
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Introduction:</b> Our previous study identified LIM homeobox domain 6 (LHX6) as a frequently epigenetically silenced tumor-suppressor gene in lung cancer.
|
28900494 |
2017 |
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Introduction:</b> Our previous study identified LIM homeobox domain 6 (LHX6) as a frequently epigenetically silenced tumor-suppressor gene in lung cancer.
|
28900494 |
2017 |
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Introduction:</b> Our previous study identified LIM homeobox domain 6 (LHX6) as a frequently epigenetically silenced tumor-suppressor gene in lung cancer.
|
28900494 |
2017 |
Trichohepatoenteric Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The syndrome is inherited in an autosomal dominant manner and has been shown to result from mutations in the LIM-homeodomain encoding LMX1B gene.
|
10571942 |
1999 |
Hepatitis C
|
0.010 |
Biomarker
|
disease |
BEFREE |
HCV infection was associated with changes in the nucleotide sequences of the binding site for the nuclear receptor family in HBV enhancer 2 (Enh2) including the BCP rather than Enh1.
|
15104371 |
2004 |
Colon Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
LIM 1215 colon cancer cells are therefore IGF-responsive but IGF-II is not a major autocrine factor for these cells in monolayer, suggesting heterogeneity between colon carcinoma cell lines with respect to the role of the IGF system.
|
11306178 |
2001 |
Malignant tumor of colon
|
0.030 |
Biomarker
|
disease |
BEFREE |
LIM 1215 colon cancer cells are therefore IGF-responsive but IGF-II is not a major autocrine factor for these cells in monolayer, suggesting heterogeneity between colon carcinoma cell lines with respect to the role of the IGF system.
|
11306178 |
2001 |
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.
|
15542589 |
2004 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
LIM domains-containing protein 1 (LIMD1) is encoded at chromosome 3p21.3, a region commonly deleted in many solid malignancies.
|
15542589 |
2004 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
LIM-only protein 4 (LMO4) plays critical roles in mammalian development, and has been proposed to play roles in epithelial oncogenesis, including breast cancer.
|
16331278 |
2006 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM-only protein 4 (LMO4) plays critical roles in mammalian development, and has been proposed to play roles in epithelial oncogenesis, including breast cancer.
|
16331278 |
2006 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM-only protein 4 (LMO4) plays critical roles in mammalian development, and has been proposed to play roles in epithelial oncogenesis, including breast cancer.
|
16331278 |
2006 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM and SH3 protein (LASP-1), initially identified from human breast cancer, is a specific focal adhesion protein involved in cell migration.
|
16430883 |
2006 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM and SH3 protein (LASP-1), initially identified from human breast cancer, is a specific focal adhesion protein involved in cell migration.
|
16430883 |
2006 |
Bipolar Disorder
|
0.390 |
Biomarker
|
disease |
BEFREE |
PDLIM5 may have a minor effect on susceptibility to BP in Caucasians.
|
18496208 |
2008 |
Pancreatic carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
LIM only 4 is overexpressed in late stage pancreas cancer.
|
19099607 |
2008 |
Malignant neoplasm of pancreas
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
LIM only 4 is overexpressed in late stage pancreas cancer.
|
19099607 |
2008 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM-only 4 (LMO4), a member of the LIM-only (LMO) subfamily of LIM domain-containing transcription factors, was initially reported to have an oncogenic role in breast cancer.
|
19099607 |
2008 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM-only 4 (LMO4), a member of the LIM-only (LMO) subfamily of LIM domain-containing transcription factors, was initially reported to have an oncogenic role in breast cancer.
|
19099607 |
2008 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells.
|
21219645 |
2011 |
Neoplasm Metastasis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 1 (LIMK1) is an actin and microtubule cytoskeleton modulatory protein that is overexpressed in a number of cancerous tissues and cells and also promotes invasion and metastasis of prostate and breast cancer cells.
|
21219645 |
2011 |
Virus Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
LIM kinase 1 modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to initiate viral infection.
|
21321123 |
2011 |
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
LIM kinase 1 (LIMK1) is implicated in cellular mechanisms regulating tumour cell invasion and may be involved in ovarian carcinoma progression.
|
22906279 |
2012 |